So is that one potential enough to scare the drug companies away so theyll never fund this type of study
Dermatologist at the Ohio State University, Susan Massick, MD, told Healthline: "Telogen effluvium [or TE] is a diffuse shedding of hair that occurs approximately three months after a major stressor." Mir Ali, MD, a California-based bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center, added: "The patients it does happen to, in my experience, notice it and see it in the hairbrush
Compounded GLP-1 helps reduce appetite and support consistent weight loss, so you can see real progress, fast
External resources New England Journal of Medicine: Retatrutide Phase 2 Trial Results FDA Drug Safety and Availability Information For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, personalized protocol tools, and a community of thousands who have navigated these exact dosing decisions